Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptoms of Schizophrenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00246194
What this trial is testing

Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)

Who this might be right for
Schizophrenia
Janssen, LP 532
Early research (Phase 1)Study completedNCT00986531
What this trial is testing

The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics

Who this might be right for
Schizophrenia
AstraZeneca 59
Not applicableStudy completedNCT00344500
What this trial is testing

Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications

Who this might be right for
DiabetesObesityWeight Gain
VA Office of Research and Development 122
Testing effectiveness (Phase 2)Study completedNCT02818777
What this trial is testing

Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University of Colorado, Denver 13
Post-approval studies (Phase 4)Study completedNCT00644800
What this trial is testing

The Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis

Who this might be right for
SchizophreniaManiaDelusional Disorder+1 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 89
Not applicableWithdrawnNCT05956600
What this trial is testing

An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms

Who this might be right for
Schizophrenia, Treatment-Resistant
University of California, Los Angeles
Testing effectiveness (Phase 2)Looking for participantsNCT06376734
What this trial is testing

Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness

Who this might be right for
Major Depressive DisorderObsessive-Compulsive DisorderSchizophrenia+5 more
Brigham and Women's Hospital 180
Not applicableNot Yet RecruitingNCT07503093
What this trial is testing

Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early Psychosis

Who this might be right for
PsychosisAnxietyDepression+1 more
Mclean Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00268749
What this trial is testing

Glycine Treatment of Prodromal Symptoms

Who this might be right for
Schizophrenia
Yale University 10
Testing effectiveness (Phase 2)Study completedNCT00905307
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 459
Not applicableUnknownNCT05695144
What this trial is testing

TDCS Combined With rTMS for Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia Negative Type
Tianjin Anding Hospital 120
Not applicableStudy completedNCT03198364
What this trial is testing

Development of a Mobile Heath Augmented Brief Suicide Prevention Intervention for People With SMI

Who this might be right for
SchizophreniaBipolar DisorderSuicide and Self-harm
University of California, San Diego 78
Not applicableUnknownNCT01382433
What this trial is testing

Chronic Cannabis Users: A Model for Negative Symptoms in Schizophrenia

Who this might be right for
Chronic Cannabis UsersHealthy Subjects
Shalvata Mental Health Center 115
Large-scale testing (Phase 3)Looking for participantsNCT03094429
What this trial is testing

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

Who this might be right for
Refractory Schizophrenia
SyneuRx International (Taiwan) Corp 287
Not applicableStudy completedNCT00163865
What this trial is testing

A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents

Who this might be right for
Mental DisordersAffective DisordersAnxiety Disorders+2 more
Bayside Health 71
Post-approval studies (Phase 4)UnknownNCT01300364
What this trial is testing

Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Fundació Sant Joan de Déu 249
Testing effectiveness (Phase 2)Study completedNCT00615511
What this trial is testing

Efficacy of Pregnenolone in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Weill Medical College of Cornell University 100
Not applicableStudy completedNCT03449407
What this trial is testing

Multi-dimensional Investigations of Negative Emotions and Drug-resistant Auditory Verbal Hallucinations in Psychosis

Who this might be right for
Schizophrenia Spectrum and Other Psychotic DisordersHallucinations, Auditory
Chinese University of Hong Kong 47
Post-approval studies (Phase 4)Looking for participantsNCT07105111
What this trial is testing

Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Neurocrine Biosciences 100
Not applicableStudy completedNCT00168311
What this trial is testing

Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Negative Symptoms in Schizophrenia

Who this might be right for
Schizophrenia
The Alfred 22
Next Page